Clinical Trial Update: Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism [Phase 2]

View source ↗

Summary

Phase 2 trial update showing results for incobotulinum toxin A (Xeomin) in treating troublesome sialorrhea in Parkinson's disease; results have been posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Sialorrhea | Phase 2 | Status: COMPLETED | Results posted: 2016-12-14